Literature DB >> 11226954

Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract.

P Ambrosch1, M Kron, O Pradier, W Steiner.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the efficacy of selective neck dissection (SND) in elective and therapeutic treatment of the neck.
METHODS: A retrospective review was undertaken of 503 previously untreated patients undergoing 711 SNDs as a part of initial therapy for squamous cell carcinoma of the larynx, oral cavity, oropharynx, and hypopharynx from August 1986 to June 1997 at a single institution. Lymph nodes were pathologically negative in 249 and positive in 254 patients. Postoperative radiotherapy was given to 14.5% of the node-negative and 62.2% of the node-positive patients. The median follow-up interval was 41 months.
RESULTS: The 3-year regional recurrence rates estimated according to Kaplan-Meier were as follows: pN0, 4.7%; pN1, 4.9%; pN2, 12.1%. A comparison of recurrence rates with respect to the extent of neck disease and postoperative radiotherapy demonstrated a tendency to an improved regional control in irradiated patients with one metastasis and a distinctly improved regional control in patients with multiple metastases or metastases with extracapsular spread.
CONCLUSION: The results achieved with SND compare favorably with the results reported for modified radical neck dissection. The application of SND might be extended to more advanced neck disease.

Entities:  

Mesh:

Year:  2001        PMID: 11226954     DOI: 10.1067/mhn.2001.111598

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  28 in total

1.  [Incidence, latency, and prognosis of local and regional recurrences in patients with upper aerodigestive tract cancer treated by laser microsurgery: influence of initial tumor parameters].

Authors:  M C Jäckel; A Martin; W Steiner
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

Review 2.  Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease.

Authors:  R A Ord
Journal:  Oral Maxillofac Surg       Date:  2012-05-13

3.  (Chemo)radiotherapy after laser microsurgery and selective neck dissection for pN2 head and neck cancer.

Authors:  Hendrik Andreas Wolff; Friedrich Ihler; Nina Zeller; Christian Welz; Klaus Jung; Martin Canis; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

Review 4.  Superselective neck dissection: rationale, indications, and results.

Authors:  Carlos Suárez; Juan P Rodrigo; K Thomas Robbins; Vinidh Paleri; Carl E Silver; Alessandra Rinaldo; Jesus E Medina; Marc Hamoir; Alvaro Sanabria; Vanni Mondin; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-16       Impact factor: 2.503

Review 5.  The evolving role of selective neck dissection for head and neck squamous cell carcinoma.

Authors:  K Thomas Robbins; Alfio Ferlito; Jatin P Shah; Marc Hamoir; Robert P Takes; Primož Strojan; Avi Khafif; Carl E Silver; Alessandra Rinaldo; Jesus E Medina
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-19       Impact factor: 2.503

6.  Relevance of Level IIb Neck Dissection in Patients with Head and Neck Squamous Cell Carcinomas.

Authors:  Seiji Hosokawa; Daiki Mochizuki; Goro Takahashi; Jun Okamura; Atsushi Imai; Ryuji Ishikawa; Yoshinori Takizawa; Takashi Yamatodani; Kiyoshi Misawa; Hiroyuki Mineta
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

7.  Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Authors:  Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger
Journal:  J Clin Oncol       Date:  2019-02-27       Impact factor: 44.544

Review 8.  Oral cavity squamous cell carcinoma and the clinically n0 neck: the past, present, and future of sentinel lymph node biopsy.

Authors:  Andrew Coughlin; Vicente A Resto
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

9.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

10.  Significance of level v lymph node dissection in clinically node positive oral cavity squamous cell carcinoma and evaluation of potential risk factors for level v lymph node metastasis.

Authors:  Devendra G Parikh; Yogen P Chheda; Shakuntala V Shah; Ashok M Patel; Mohit R Sharma
Journal:  Indian J Surg Oncol       Date:  2013-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.